These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 27878673)
1. Reforming the Swedish pharmaceuticals market: consequences for costs per defined daily dose. Bergman MA; Granlund D; Rudholm N Int J Health Econ Manag; 2016 Sep; 16(3):201-214. PubMed ID: 27878673 [TBL] [Abstract][Full Text] [Related]
2. Impact of European pharmaceutical price regulation on generic price competition: a review. Puig-Junoy J Pharmacoeconomics; 2010; 28(8):649-63. PubMed ID: 20515079 [TBL] [Abstract][Full Text] [Related]
3. OSTEOPOROSIS DRUGS MARKETED IN THE UNITED STATES: GENERIC COMPETITION, PRICING STRUCTURE, AND DISPERSION AMONG PAYERS. Balkhi B; Seoane-Vazquez E; Rodriguez-Monguio R Int J Technol Assess Health Care; 2016 Jan; 32(6):385-392. PubMed ID: 28065194 [TBL] [Abstract][Full Text] [Related]
4. Costs of paying higher prices for equivalent effects on the Pharmaceutical Benefits Scheme. Karnon J; Edney L; Sorich M Aust Health Rev; 2017 Mar; 41(1):1-6. PubMed ID: 26954612 [TBL] [Abstract][Full Text] [Related]
5. Reference pricing with endogenous generic entry. Brekke KR; Canta C; Straume OR J Health Econ; 2016 Dec; 50():312-329. PubMed ID: 27350294 [TBL] [Abstract][Full Text] [Related]
6. High prices for generics in Australia - more competition might help. Bulfone L Aust Health Rev; 2009 May; 33(2):200-14. PubMed ID: 19563309 [TBL] [Abstract][Full Text] [Related]
7. Product-line extensions and pricing strategies of brand-name drugs facing patent expiration. Hong SH; Shepherd MD; Scoones D; Wan TT J Manag Care Pharm; 2005; 11(9):746-54. PubMed ID: 16300418 [TBL] [Abstract][Full Text] [Related]
8. Price competition in pharmaceuticals - Evidence from 1303 Swedish markets. Granlund D; Bergman MA J Health Econ; 2018 Sep; 61():1-12. PubMed ID: 30007260 [TBL] [Abstract][Full Text] [Related]
9. Competition between brand-name and generics--analysis on pricing of brand-name pharmaceutical. Kong Y Health Econ; 2009 May; 18(5):591-606. PubMed ID: 18816580 [TBL] [Abstract][Full Text] [Related]
10. Impact of a generic substitution reform on patients' and society's expenditure for pharmaceuticals. Andersson K; Bergström G; Petzold MG; Carlsten A Health Policy; 2007 May; 81(2-3):376-84. PubMed ID: 16945449 [TBL] [Abstract][Full Text] [Related]
11. Dynamic competition in pharmaceuticals. Patent expiry, generic penetration, and industry structure. Magazzini L; Pammolli F; Riccaboni M Eur J Health Econ; 2004 Jun; 5(2):175-82. PubMed ID: 15452754 [TBL] [Abstract][Full Text] [Related]
12. Do generics offer significant savings to the UK National Health Service? Kanavos P Curr Med Res Opin; 2007 Jan; 23(1):105-16. PubMed ID: 17257472 [TBL] [Abstract][Full Text] [Related]
13. Price regulation and generic competition in the pharmaceutical market. Dalen DM; Strøm S; Haabeth T Eur J Health Econ; 2006 Sep; 7(3):208-14. PubMed ID: 16841230 [TBL] [Abstract][Full Text] [Related]
14. The effect of generic competition on the price of brand-name drugs. Lexchin J Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552 [TBL] [Abstract][Full Text] [Related]
15. Pharmaceutical policy in the Netherlands: from price regulation towards managed competition. Boonen LH; van der Geest SA; Schut FT; Varkevisser M Adv Health Econ Health Serv Res; 2010; 22():53-76. PubMed ID: 20575228 [TBL] [Abstract][Full Text] [Related]
16. Decreasing utilization and increasing prices of brand-name oral contraceptive pills: Implications to societal costs and market competition. Zhang JX PLoS One; 2020; 15(6):e0234463. PubMed ID: 32525965 [TBL] [Abstract][Full Text] [Related]
17. Bib Pharma Monopoly: Why Consumers Keep Landing on "Park Place" and How the Game is Rigged. Levy MS Am Univ Law Rev; 2016; 66(1):247-303. PubMed ID: 28225582 [TBL] [Abstract][Full Text] [Related]
18. The Impact of Price-cap Regulations on Exit by Generic Pharmaceutical Firms. Zhang W; Guh D; Sun H; Marra CA; Lynd LD; Anis AH Med Care; 2016 Sep; 54(9):884-90. PubMed ID: 27213540 [TBL] [Abstract][Full Text] [Related]
19. Competition and the Reference Pricing Scheme for pharmaceuticals. Ghislandi S J Health Econ; 2011 Dec; 30(6):1137-49. PubMed ID: 21937137 [TBL] [Abstract][Full Text] [Related]
20. Trends and determinants of retail prescription drug costs. Teasdale B; Nguyen A; van Meijgaard J; Schulman KA Health Serv Res; 2022 Jun; 57(3):548-556. PubMed ID: 35211965 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]